Family Offices Increase Deal Activity in Biotech Sector
TL;DR
In June, family offices increased their investment activity, making 60 direct investments, particularly in biotech and healthcare firms like Antheia, driven by a desire for impactful and profitable scientific breakthroughs, leveraging their patient capital.
Want the full story? Read the original reporting
Read on CNBC